Bram, France
Evaluation of the Future of Adolescents and Young Adults Received in an Early Care System
Psychic suffering is very common among young people; a public health issue in France is to improve its early identification and treatment. To this end, the Fondation Santé des Etudiants de France (FSEF) has developed ambulatory systems in France called "Relais Collégiens-Lycéens-Etudiants" offering adolescents and young adults a reception, evaluation and support or a quick referral. The FSEF Relay system allows a wide range of subjects to benefit from rapid support for a situation of mental suffering, which specialized care structures cannot do. In fact, first of all, if the school teams and the entourage are not made aware of the need to be attentive to psychological suffering, it is not detected, then when it is, most of these young people are not. not addressed out of reluctance from those around them or from the young person himself who refuse to go to psychiatric care experienced as stigmatizing; then, when young people are referred to care structures, consultation times are unsuitable (saturated structures) while these young people need a rapid response. The impact of early detection systems in adolescence has been little studied, this research proposes to initiate such an approach on a large panel of young people from a systematic evaluation, by evaluating the future in the short and medium term. This research proposes to assess the impact of these devices. T his is a prospective clinical epidemiology study based on the naturalistic follow-up of a cohort of 1,500 young people aged 11 to 25 presenting consecutively over the course of one year at the 5 Relais d'Ile de France. Young people will be assessed on entry into the system (T0), at the end of the follow-up (T1) and 6 months after the end of the follow-up (T6). The data collected will be: - The state of health (including mental health, somatic health and drug consumption), lifestyle and education and social adaptation through clinical assessment and self-questionnaires completed by young people: - The clinical assessment includes the following elements: the severity of the psychological suffering (CGI, Global Clinical Impression), the psychosocial impact (SOFAS, Social and Occupational Functioning Assessment Scale) and the diagnosis of mental disorder according to the ICD 10 (International Classification) 10th Revision) when relevant. - The self-questionnaires assess psychological suffering (K10, Kessler scale 10 items), social functioning (WSAS, Work Social Adjustment Scale) as well as satisfaction with the care provided (CSQ-8, Client Satisfaction Questionnaire 8 items, and Likert scale, at T1 and T6). - The EDGAR grid (Interview, Approach, Group, Support, Meeting) to quantify the care offered at the Relais and their cost. - The orientation that may be offered following this support
Phase
N/ASpan
78 weeksSponsor
Fondation Santé des Étudiants de FranceSceaux
Recruiting
Validation and Standardisation of a "Neuralix" Digital Ecological Battery
Phase
N/ASpan
108 weeksSponsor
Direction Centrale du Service de Santé des ArméesClamart
Recruiting
Healthy Volunteers
Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk
Phase
4Span
170 weeksSponsor
University Hospital, BrestClamart
Recruiting
Validation of the French Version of the Edinburgh Postnatal Depression Scale (EPDS) Postnatally in the Father
Phase
N/ASpan
62 weeksSponsor
Groupe Hospitalier du HavreClamart
Recruiting
Healthy Volunteers
Shared Decision-making Process for Unprovoked vEnous THromboEmbolism Management. (ETHER )
Phase
N/ASpan
188 weeksSponsor
University Hospital, BrestClamart
Recruiting
French Observatory for Patients with Type 3 Glycogenosis
Phase
N/ASpan
696 weeksSponsor
Institut de Myologie, FranceClamart
Recruiting
Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome
Phase
2Span
308 weeksSponsor
GenethonClamart
Recruiting
Results From a French Temporary Utilization Authorization of First-line Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Chemotherapy (IC), Treated With Venetoclax Azacitidine
Phase
N/ASpan
39 weeksSponsor
French Innovative Leukemia OrganisationClamart
Recruiting
Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome
The present project is part of a more global project called BIOMINRISK for which 3 axes will be explored: Genetics (a project which will be detailed here), Neurobiology and Radio-anatomical. This is a multicenter (15 centers), national, non-randomized, open-label, genetic study. Sudden unexpected death in infant (SUDI) cases will be included (i) partly retrospectively (infants already included in the national French SUDI registry) and (ii) for the other cases, prospectively at the time of care of the deceased infant by the referral center of SUDI participating in the project. The parents making up the trios will be included prospectively. Once the Sudden infant death syndrome (SIDS) cases have been identified among all the included SUDI cases (following the results of post-mortem examinations), Whole Genome Sequencing (WGS) will be carried out on these SIDS cases and their two parents, in order to identify pathogenic allelic variants. The data generated by this sequencing will then be analyzed using a trio approach to search for de novo variants, i.e. variants present in the infant who died of SIDS and absent from the genome of both parents.
Phase
N/ASpan
166 weeksSponsor
Nantes University HospitalClamart
Recruiting
Association of Dysbiosis and Immune Response in Bronchiolitis in Under 12 Months -Old Infants
Phase
N/ASpan
73 weeksSponsor
Assistance Publique - Hôpitaux de ParisClamart
Recruiting